NANCY GERMANY: Open Payments
NPI 1760418131 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 38 payments from 11 companies in 2025. Trend: 2023 $511 · 2024 $490 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $311 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| PFIZER INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: QULIPTA, UBRELVY, RELISTOR, NURTEC ODT, Symbravo, Evoke, ETERNA, TONMYA.
Industry payments across LA — which companies pay providers there.
